lol646m

Redmi 14C 5G India Launch: The Redmi 14C 5G is likely to be a rebranded version of the Redmi 14R 5G, which debuted in China this September. Redmi 14C 5G India Launch: Xiaomi sub-brand has officially announced the launch date of the Redmi 14C 5G smartphone in India as well as select global markets after launching the Redmi Note 14 series. The handset will launch in India on January 6, 2025, according to an official landing page. It will be arriving as the successor to the Redmi 13C 5G handset that debuted in the country last December in the year 2024. Both Flipkart and Amazon have put up a microsite confirming the smartphone’s availability on the e-commerce platforms respectively. As per the microsite, the upcoming smartphone will be available in Purple with a gradient finish, Black, and Blue with star trails-like design colour options. The Redmi 14C 5G is likely to be a rebranded version of the Redmi 14R 5G, which debuted in China this September. Redmi 14C 5G Price In India And Availability (Expected) According to reports, the Redmi 14C is expected to be priced between Rs 11,000 to Rs 12,000. However, the company has not confirmed the exact details of the pricing as of now. A live Amazon microsite for the handset hints at its eventual Amazon availability alongside the company e-store. Redmi 14C 5G Specifications (Expected) The smartphone is anticipated to feature a 6.68-inch HD+ LCD display with a smooth 120Hz refresh rate, promising an immersive viewing experience. The device is expected to run on Android 14-based HyperOS, delivering a seamless and intuitive user interface. The smartphone is expected to run on Android 14-based HyperOS, delivering a seamless and intuitive user interface. Under the hood, the phone could be powered by the Snapdragon 4 Gen 2 SoC, paired with a robust 5,160mAh battery supporting 18W fast charging for extended usability. On the photography front, the handset is set to sport a 50MP AI-powered main camera, complemented by a 5MP front camera for selfies. The rear camera module is a standout design element, featuring a centrally placed circular module that houses a dual-camera setup and an LED flash unit. Stay informed on all the latest news , real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.Rookie Brian Thomas Jr. scores again as Jaguars beat Titans 20-13 for rare series sweep

Blackhawks fire head coach Luke Richardson after 8-16-2 start

Dazostinag sodium is under clinical development by and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData, Phase I drugs for Non-Small Cell Lung Cancer have an 80% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Dazostinag sodium overview Dazostinag sodium (TAK-676) is under development for the treatment of advanced or metastatic solid tumors including non-small cell lung cancer, triple-negative breast cancer (TNBC), oropharyngeal cancer, colorectal cancer and head and neck cancer squamous cell carcinoma. The drug candidate is cyclic purine dinucleotide and acts by targeting stimulator of interferon genes (STING/TMEM173). It is a new molecular entity. It is administered via intravenous route. Takeda Pharmaceutical overview (Takeda) is a global pharmaceutical company primarily engaged in the research, development, production, and commercialization of biopharmaceutical products. It provides treatment for inflammatory bowel disease, acid-related diseases, motility disorders and liver diseases; hemophilia and hereditary bleeding disorders; primary immunodeficiency and multifocal motor neuropathy; major depressive disorder and attention-deficit hyperactivity disorder; and its cancer treatment encompasses multiple myeloma, mantle cell lymphoma, non-small cell lung cancer and chronic myeloid leukemia. While the company markets its pharmaceutical products directly, it also collaborates with marketing alliance partners in worldwide. Takeda operates in various countries worldwide, including Japan, the US, Europe, Latin America, Africa, the Middle East, and the Asia Pacific region. Takeda is headquartered in Tokyo, Japan. For a complete picture of Dazostinag sodium’s drug-specific PTSR and LoA scores, This content was updated on 12 April 2024 From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s .

Nimbus and Toshiba Announce Joint Development of Next-Generation Pure Hydrogen Fuel Cell Stack Aiming to realize a versatile fuel cell stack applicable to buses, trucks, and stationary uses GROTON, Conn., Nov. 20, 2024 /PRNewswire-PRWeb/ — and have signed a joint development agreement for a next-generation pure hydrogen fuel cell stack applicable to various large mobility applications, such as buses and trucks, as well as stationary uses. Under this agreement, Nimbus will combine its patented “four-fluid stack technology” with Toshiba’s long-established to jointly develop the pure hydrogen fuel cell stack. Nimbus possesses technology for fuel cells aimed at large mobility applications like buses and trucks. Its “four-fluid stack technology” is an innovative approach that combines porous and metal separators to supply four fluids: hydrogen, air, pure water, and antifreeze, enabling stable and efficient operation at high output. Toshiba has extensive experience in manufacturing fuel cells and possesses commercialization and mass production technology using porous separators. Through this joint development, both companies aim to create a pure hydrogen fuel cell stack with high power density, reliability, durability, and cost-effectiveness, suitable for various applications, including large mobility and stationary fuel cell systems, which are expected to grow in the market. Nimbus and Toshiba will contribute to the expansion of the hydrogen value chain and the development of a decarbonized society through this strategic partnership. President and Co-Founder of Nimbus, stated, “We are excited to accelerate product commercialization in collaboration with Toshiba, a pioneer in fuel cell development, with a proven track record in the stationary market.” , Vice President of the Energy Aggregation Division at Toshiba, commented, “Our partnership with Nimbus aligns with our mission, and we will focus on the early commercialization of competitive fuel cell stacks applicable to various uses.” the latest news shaping the hydrogen market at Nimbus and Toshiba Announce Joint Development of Next-Generation Pure Hydrogen Fuel Cell Stack, SFC Energy AG renews framework contract with Fuel Cell Systems Ltd worth EUR 5.5 million for 2025 Brunnthal/Munich, Germany, November 21, 2024 – SFC Energy AG (“SFC”, F3C:DE, ISIN: DE0007568578), a leading provider of... Department of Energy Issues Call for Hydrogen Fuel Cell Commercialization Partners to Support the Launch of L’Innovator 2.0 The U.S. Department of Energy (DOE), in partnership with Los Alamos National Laboratory (LANL)... Ricardo’s hydrogen fuel cell module celebrates key milestone to successfully generating power Initially developed to generate high energy output with zero-emissions for the maritime sector as part of the Sustainable...